Immune regulation of osteoclast function in postmenopausal osteoporosis: A critical interdisciplinary perspective

International Journal of Medical Sciences

Volumn 9, Issue 9, 2012, Pages 825-832

  Zhao, Renqing ^a  

^a ZHEJIANG NORMAL UNIVERSITY   (China)

Author keywords

Cytokine; Estrogen deficiency; Osteoclast; Osteoimmunology

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INTERLEUKIN 6; INTERLEUKIN 7; TUMOR NECROSIS FACTOR;

BONE ATROPHY; CELL FUNCTION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ESTROGEN DEFICIENCY; HUMAN; IMMUNOREGULATION; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; ESTROGENS; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-7; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; RECEPTORS, ESTROGEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84868584513     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5180     Document Type: Review

References (78)

1. Mcnamara L M. Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures. J R Soc Interface, 2010; 7(44):353-72.
2. Lerner U H. Bone remodeling in post-menopausal osteoporosis. J Dent Res, 2006; 85(7):584-95.
3. Rosen C J. Pathogenesis of osteoporosis. Baillieres Best Pract Res Clin Endocrinol Metab, 2000; 14(2):181-93.
4. Jilka R L, Passeri G, Girasole G, et al. Estrogen loss upregulates hematopoiesis in the mouse: a mediating role of IL-6. Exp Hematol, 1995; 23(6):500-6.
5. Jilka R L, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science, 1992; 257(5066):88-91.
6. Bell K, Loveridge N, Lunt M, et al. Oestrogen suppression increases Haversian resorption depth as well as remodelling activity in women with endometriosis. Bone, 1996; 19:131S.
7. Di Gregorio G B, Yamamoto M, Ali a A, et al. Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol. J Clin Invest, 2001; 107(7):803-12.
8. Jilka R L, Takahashi K, Munshi M, et al. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. J Clin Invest, 1998; 101(9):1942-50.
9. Kousteni S, Han L, Chen J R, et al. Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest, 2003; 111(11):1651-64.
10. Kousteni S, Bellido T, Plotkin L I, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell, 2001; 104(5):719-30.
11. Ascenzi P, Bocedi A and Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med, 2006; 27(4):299-402.
12. Nilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev, 2001; 81(4):1535-65.
13. Smith C L and O'malley B W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev, 2004; 25(1):45-71.
14. Tsai M J and O'malley B W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem, 1994; 63:451-86.
15. Acconcia F and Kumar R. Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett, 2006; 238(1):1-14.
16. Safe S. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm, 2001; 62:231-52.
17. Levin E R. Cellular functions of plasma membrane estrogen receptors. Steroids, 2002; 67(6):471-5.
18. Kelly M J and Levin E R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab, 2001; 12(4):152-6.
19. Michael H, Harkonen P L, Vaananen H K, et al. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res, 2005; 20(12):2224-32.
20. Nakashima T and Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol, 2009; 29(5):555-67.
21. Pacifici R. The immune system and bone. Arch Biochem Biophys, 2010; 503(1):41-53.
22. Breuil V, Ticchioni M, Testa J, et al. Immune changes in post-menopausal osteoporosis: the Immunos study. Osteoporos Int, 2010; 21(5):805-14.
23. Adolfsson J, Borge O J, Bryder D, et al. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity, 2001; 15(4):659-69.
24. Akashi K, Traver D, Miyamoto T, et al. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature, 2000; 404(6774):193-7.
25. Kondo M, Weissman I L and Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell, 1997; 91(5):661-72.
26. Mandel E M and Grosschedl R. Transcription control of early B cell differentiation. Curr Opin Immunol, 2010; 22(2):161-7.
27. Kondo M, Wagers a J, Manz M G, et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol, 2003; 21:759-806.
28. Nakashima T and Takayanagi H. Osteoclasts and the immune system. J Bone Miner Metab, 2009; 27(5):519-29.
29. Caetano-Lopes J, Canhao H and Fonseca J E. Osteoimmunology--the hidden immune regulation of bone. Autoimmun Rev, 2009; 8(3):250-5.
30. Quinn J M and Saleh H. Modulation of osteoclast function in bone by the immune system. Mol Cell Endocrinol, 2009; 310(1/2):40-51.
31. Okamoto K and Takayanagi H. Regulation of bone by the adaptive immune system in arthritis. Arthritis Res Ther, 2011; 13(3):219.
32. Islander U, Jochems C, Lagerquist M K, et al. Estrogens in rheumatoid arthritis; the immune system and bone. Mol Cell Endocrinol, 2011; 335(1):14-29.
33. Maruotti N, Grano M, Colucci S, et al. Osteoclastogenesis and arthritis. Clin Exp Med, 2011; 11(3):137-45.
34. Karmakar S, Kay J and Gravallese E M. Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention. Rheum Dis Clin North Am, 2010; 36(2):385-404.
35. Pacifici R. T cells: critical bone regulators in health and disease. Bone, 2010; 47(3):461-71.
36. Kosa J P, Balla B, Kiss J, et al. Postmenopausal expression changes of immune system-related genes in human bone tissue. J Clin Immunol, 2009; 29(6):761-8.
37. D'amelio P, Grimaldi A, Di Bella S, et al. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone, 2008; 43(1):92-100.
38. Cenci S, Weitzmann M N, Roggia C, et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest, 2000; 106(10):1229-37.
39. Weitzmann M N, Roggia C, Toraldo G, et al. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest, 2002; 110(11):1643-50.
40. Wei S, Kitaura H, Zhou P, et al. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest, 2005; 115(2):282-90.
41. Zheng S X, Vrindts Y, Lopez M, et al. Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas, 1997; 26(1):63-71.
42. Poli V, Balena R, Fattori E, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. Embo J, 1994; 13(5):1189-96.
43. Lee S K, Kadono Y, Okada F, et al. T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res, 2006; 21(11):1704-12.
44. Anginot A, Dacquin R, Mazzorana M, et al. Lymphocytes and the Dap12 adaptor are key regulators of osteoclast activation associated with gonadal failure. PLoS One, 2007; 2(7):e585.
45. Roggia C, Gao Y, Cenci S, et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A, 2001; 98(24):13960-5.
46. Gao Y, Qian W P, Dark K, et al. Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. Proc Natl Acad Sci U S A, 2004; 101(47):16618-23.
47. Gao Y, Grassi F, Ryan M R, et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest, 2007; 117(1):122-32.
48. Grassi F, Tell G, Robbie-Ryan M, et al. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci U S A, 2007; 104(38):15087-92.
49. Li J Y, Tawfeek H, Bedi B, et al. Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci U S A, 2011; 108(2):768-73.
50. Robbie-Ryan M, Pacifici R and Weitzmann M N. IL-7 drives T cell-mediated bone loss following ovariectomy. Ann N Y Acad Sci, 2006; 1068:348-51.
51. Rogers A and Eastell R. The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood. Bone, 2001; 29(1):30-4.
52. Goldschneider I. Cyclical mobilization and gated importation of thymocyte progenitors in the adult mouse: evidence for a thymus-bone marrow feedback loop. Immunol Rev, 2006; 209:58-75.
53. Ryan M R, Shepherd R, Leavey J K, et al. An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc Natl Acad Sci U S A, 2005; 102(46):16735-40.
54. Kimble R B, Bain S and Pacifici R. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res, 1997; 12(6):935-41.
55. Ammann P, Rizzoli R, Bonjour J P, et al. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest, 1997; 99(7):1699-703.
56. Cenci S, Toraldo G, Weitzmann M N, et al. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci U S A, 2003; 100(18):10405-10.
57. Edwards C J and Williams E. The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis. Osteoporos Int, 2010; 21(8):1287-93.
58. De Benedetti F, Rucci N, Del Fattore A, et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum, 2006; 54(11):3551-63.
59. Girasole G, Jilka R L, Passeri G, et al. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest, 1992; 89(3):883-91.
60. Stein B and Yang M X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol, 1995; 15(9):4971-9.
61. Ralston S H. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res, 1994; 9(6):883-90.
62. Holt I, Davie M W and Marshall M J. Osteoclasts are not the major source of interleukin-6 in mouse parietal bones. Bone, 1996; 18(3):221-6.
63. Hattersley G, Dorey E, Horton M A, et al. Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J Cell Physiol, 1988; 137(1):199-203.
64. Udagawa N, Takahashi N, Katagiri T, et al. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med, 1995; 182(5):1461-8.
65. Bellido T, Stahl N, Farruggella T J, et al. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest, 1996; 97(2):431-7.
66. Kurihara N, Bertolini D, Suda T, et al. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol, 1990; 144(11):4226-30.
67. Devlin R D, Reddy S V, Savino R, et al. IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)2D3, on osteoclast-like cell formation in normal human bone marrow cultures. J Bone Miner Res, 1998; 13(3):393-9.
68. Ross F P. Interleukin 7 and estrogen-induced bone loss. Trends Endocrinol Metab, 2003; 14(4):147-9.
69. Lee S K and Surh C D. Role of interleukin-7 in bone and T-cell homeo-stasis. Immunol Rev, 2005; 208:169-80.
70. Weitzmann M N, Cenci S, Rifas L, et al. Interleukin-7 stimulates osteo-clast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood, 2000; 96(5):1873-8.
71. Toraldo G, Roggia C, Qian W P, et al. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci U S A, 2003; 100(1):125-30.
72. Borger P, Kauffman H F, Postma D S, et al. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J Immunol, 1996; 156(4):1333-8.
73. Katavic V, Grcevic D, Lee S K, et al. The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors. Bone, 2003; 32(6):581-90.
74. Sato T, Shibata T, Ikeda K, et al. Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res, 2001; 16(12):2215-21.
75. Kobayashi K, Takahashi N, Jimi E, et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med, 2000; 191(2):275-86.
76. Dinarello C A. The interleukin-1 family: 10 years of discovery. Faseb J, 1994; 8(15):1314-25.
77. Harada S, Yamamura M, Okamoto H, et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum, 1999; 42(7):1508-16.
78. Tian B, Nowak D E, Jamaluddin M, et al. Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling. J Biol Chem, 2005; 280(17):17435-48.